Dr. David Acheson and Ben Miller, Ph.D. discuss how food companies can responsibly re-open, resume operations, and rebound from early-2020 COVID outbreaks.
Former FDA Chief Medical Officer David Acheson, MD, updates us on the food industry on the next phase of COVID-19. Joining Dr. Acheson is Ben Miller, Ph.D., renowned epidemiologist and...
Ben Miller, Ph.D., from The Acheson Group, covers what is known about methods of transmission and prevention, the Coronavirus' ability to thrive on surfaces & in certain conditions, and ways...
This month’s FSMA Friday special guest is Dr. Liliana Casal-Wardle - Senior Director of Food Safety at The Acheson Group. In addition to recapping FSMA news from January, she'll share...
This month’s FSMA Friday special guest is none other than the highly acclaimed David Acheson, MD, CEO and President of the Acheson Group, one of the food industry’s premier global...
In addition to recapping November, 2019 FSMA news and changes, Dr. Liliana Casal-Wardle from The Acheson Group helps explain aligning food safety programs and culture to minimize risk.
After a brief update on the FSMA IA Rule, Dr. Ben Miller discusses the threats facing food and beverage companies from the uptick of Hepatitis A outbreaks and offers sound...
Cameron Prince from TAG summarizes the Importer Preventive Controls Under SFCR: a critical topic for those who ship to Canada. Register here to be included in future FSMA Friday sessions:...
In addition to recapping August, 2019 FSMA news and changes, Eric Edmunds, JD, will deliver
In addition to recapping July, 2019 FSMA news and changes, Anabelle Broadbent dives into Food Safety of Sprouts: Understanding and implementation of the requirements in FSMA Produce Safety Rule, and...
In addition to recapping June, 2019 FSMA news and changes, Peyman Fatemi from TAG dives into Your Environmental Monitoring Program as Part of the Environmental Control Strategy.
In addition to recapping May, 2019 FSMA news and changes, Rolando González and Chris Snabes from TAG dive into Food Defense and the recent messages conveyed by the FDA that...